Inhlaler. (shutterstock) shutterstock
Inhlaler

Israel’s “miracle drug” produced remarkable results fighting COVID-19 in a phase one trial.

A new Israeli coronavirus medicine called EXO-CD24 was administered to 30 patients with moderate or worse coronavirus conditions. All 30 recovered, with 29 of the patients recovering in three to five days.

According to Tel Aviv’s Ichilov Medical Center, the results represent a “huge breakthrough.” The medicine is administered via an inhaler.

“If this succeeds, it will be huge, simply huge,” commented Prime Minister Benjamin Netanyahu.